don’t ask me that. No one knows but we are not a 9 million market cap
All we know is the fundamentals
- CEO and directors buying more at 7.5 cents one month before potential GLP results then straight into phase 1
- 10 million in funding
- 5-10 million dollar grant on Walter Reed study
- phase 1 is for both stroke and traumatic brain injury ( CEO calls is 2 for one study and saves us millions)
- Peers in this space in the same position as us are 70-100 million dollar market caps
it went up from 2 cents to 15 cents there is too many donkeys in the money and selling below out funding and below the CEO just funny
don’t ask me that. No one knows but we are not a 9 million...
Add NYR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.7¢ |
Change
-0.001(1.72%) |
Mkt cap ! $10.22M | |||
| Open | High | Low | Value | Volume |
| 5.8¢ | 5.8¢ | 5.6¢ | $14.12K | 245.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 79794 | 5.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.3¢ | 127843 | 1 |
View Market Depth
| Last trade - 15.50pm 31/05/2024 (20 minute delay) ? |
|
|||||
|
Last
5.7¢ |
Change
-0.001 ( 1.72 %) |
||||
| Open | High | Low | Volume | ||
| 5.9¢ | 5.9¢ | 5.6¢ | 90169 | ||
| Last updated 15.50pm 31/05/2024 ? | |||||
| NYR (ASX) Chart |